CEO Luke Kissam framed the transition as a move toward greater agility and operational focus, aiming to address the escalating challenges of modern farming. The company enters this chapter with a strong financial tailwind, having grown its crop protection revenue by more than $1 billion between 2020 and 2025. During that same period, operating EBITDA margins for the segment expanded by roughly 250 basis points, reflecting a deliberate pivot toward high-value, differentiated technologies.
In section Releases
Corteva Pivots to Pure-Play Crop Protection After Seed Business Spin-Off
Indianapolis-based Corteva has finalized the separation of its seed and genetics division, signaling a strategic shift toward a focused crop protection model. The company now enters a new phase of its corporate evolution, prioritizing an $11 billion pipeline of chemical and biological solutions for global agricultural markets.
These specialized products now account for approximately 65% of the company's total sales. With a workforce of nearly 9,000 employees spanning 110 countries, Corteva is betting its future growth on an aggressive research agenda. The firm plans to launch 12 new active ingredients over the coming decade, including five biological products, leveraging its proprietary platforms in microbial discovery and predictive safety to secure its position as a global leader in the sector.
Comments (0)
No comments yet. Be the first!